Wonderful article and I see Thomas Barnard who has
Post# of 36507
![](/assets/46931549/no_avatar_available_thumb.jpg)
“It is important to pursue vaccine approaches other than the unproven RNA path. The Ii-key peptide approach of NGIO/GNBT should be funded by the government with several hundred million dollars.
Instead, effective lobbyists have persuaded the government to buy the entire supply of a mediocre drug of Gilead's called remdesivir.
Thanks for your article, which brings an important vaccine platform to investor's attention.”
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)